| Exchange | Price | % Move |
|---|---|---|
| CSE:EXM | ||
| FSE:A2PAW2 |
-
EXM is a non-recreational cannabis company, focused on the medical and nutraceutical uses of the compounds found within the plant.
Learn More -
Our relentless focus on innovation will drive revolution in the cannabis industry for years to come
Learn More -
Our experts come from diverse backgrounds in traditional extraction and large-scale distillation
Learn More -
Innovation in refining and next-generation product drive our advantage in Portugal
Learn More -
Revenue Growth based on Cost Competitive Cultivation and High Yield Extraction
Learn More -
Massive cultivation potential from our assets
Learn More -
We are committed to developing strong partnerships and a long-lasting positive impact
Learn More
Medical grade ingredients
EXMceuticals (“EXM”) is a medical cannabis company that strongly believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with high ambitions and potential in becoming one of the lowest-cost producers of high-grade cannabis and hemp ingredients in the world. We focus on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry.
Research Driven
Research-driven in cannabis extraction, distillation, purification and cannabinoid isolation with industry leading scientists
Innovation
Fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery for the transformation of cannabis-based ingredients.
Medical
Focused on providing the right ingredients to consumer goods infused products, capsules and oils for the medicinal and wellness industry.We control our cultivation, extraction, refining and manufacturing practices
Investor information
EXMceuticals Inc. Sets Sights On €200 Billion value on European and US combined cannabis market.
Our Portugal R&D and refinery hub is designed for purifying the extracts produced by EXMFarming and will serve as the gateway to distribute manufactured materials in Europe and North America.
Updates
Research and Development
EXMceuticals's fully operational R&D laboratory in Portugal will now develop cannabis-based formulations for products and operate as a pilot-scale refinery ...
EXMceuticals obtains its research and development
EXMceuticals Portugal has obtained the authorization for cannabis research and development from INFARMED, the Portuguese National Authority of Medicines and ...